Today, the U.S. Food and Drug Administration (FDA) announced that it has issued a “safe to proceed” letter to Revolution Medicines, allowing the company to initiate an expanded access treatment ...
Gain practical, real-world strategies to improve outcomes in pancreatic ductal adenocarcinoma (PDAC). This expert-led CME program explores early molecular profiling, precision treatment planning, and ...
As members of the PanCAN Survivor Council, we serve as ambassadors of hope for anyone affected by pancreatic cancer. We recognize the importance of not going through this journey alone, and the ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
Follow along as the PanCAN community speaks up, stands together and contacts Congress to prioritize patients and researchers ...
PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...
With Pancreatic Cancer Research at an Extraordinary Turning Point, PanCAN Unveils Ambitious 5-Year, $250 Million Campaign to ...
Through PanCAN’s All Together We Can campaign, we’re making our boldest investment yet – $250 million over five years – to ...
Streamer Thomas Donohue shares about his fundraising for PanCAN PurpleStride to honor his dad, John, who passed away from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results